Table 1.
Characteristics of patients diagnosed with PDAC.
| Pre-Pandemic (n = 125) |
Pandemic (n = 78) |
||
|---|---|---|---|
| Gender | |||
| Female | 64 (51%) | 39 (50%) | p = 0.98 |
| Male | 61 (49%) | 39 (50%) | |
| Age | |||
| Median | 72 years | 76 years | p = 0.28 |
| IQR | 17 years | 16 years | |
| Ethnic background | |||
| Any White | 89 (71%) | 56 (72%) | p = 0.25 |
| Any Asian | 2 | 1 | |
| Any Black | 2 | 0 | |
| Any mixed or other | 0 | 2 | |
| Unknown or not stated | 32 (26%) | 19 (24%) | |
| Stage | |||
| Stage 1 | 12 (10%) | 5 (6%) | p = 0.68 |
| Stage 2 | 12 (10%) | 6 (8%) | |
| Stage 3 | 39 (31%) | 22 (28%) | |
| Stage 4 | 62 (50%) | 45 (58%) | |
| Performance status | |||
| PS 0 | 42 (34%) | 21 (27%) | p = 0.44 |
| PS 1 | 40 (32%) | 31 (39%) | |
| PS 2 | 30 (24%) | 16 (21%) | |
| PS 3 | 11 (9%) | 10 (13%) | |
| PS 4 | 2 (2%) | 0 | |
| Referral source | |||
| Primary care | 56 (45%) | 26 (33%) | p = 0.14 |
| Secondary care | 69 (55%) | 52 (67%) |
Age significance value by two-sample t-test. All other significance values by chi-squared test.